These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38723940)

  • 1. Natural compound screening predicts novel GSK-3 isoform-specific inhibitors.
    Ahmad F; Gupta A; Marzook H; Woodgett JR; Saleh MA; Qaisar R
    Biochimie; 2024 Oct; 225():68-80. PubMed ID: 38723940
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Emmerich TD; Hayes JM
    Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease.
    Paudel P; Seong SH; Zhou Y; Park CH; Yokozawa T; Jung HA; Choi JS
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30413117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3α (GSK-3α): Development and impact on temozolomide treatment of glioblastoma cells.
    Hasyeoui M; Lassagne F; Erb W; Nael M; Elokely KM; Chaikuad A; Knapp S; Jorda A; Vallés SL; Quissac E; Verreault M; Robert T; Bach S; Samarat A; Mongin F
    Bioorg Chem; 2023 May; 134():106456. PubMed ID: 36913879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia.
    Wang Y; Dou X; Jiang L; Jin H; Zhang L; Zhang L; Liu Z
    Eur J Med Chem; 2019 Jun; 171():221-234. PubMed ID: 30925338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and
    Eldehna WM; Al-Rashood ST; Al-Warhi T; Eskandrani RO; Alharbi A; El Kerdawy AM
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):270-285. PubMed ID: 33327806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival.
    Liang MH; Chuang DM
    J Biol Chem; 2007 Feb; 282(6):3904-17. PubMed ID: 17148450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based design of Marine-derived Meridianin C derivatives as glycogen synthase kinase 3β inhibitors with improved oral bioavailability: From aminopyrimidyl-indoles to the sulfonyl analogues.
    Han S; Zhou W; Zhuang C; Chen F
    Bioorg Chem; 2022 Feb; 119():105537. PubMed ID: 34902644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefit.
    Umbarkar P; Ruiz Ramirez SY; Toro Cora A; Tousif S; Lal H
    Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166724. PubMed ID: 37094727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel hybrid virtual screening protocol based on pharmacophore and molecular docking for discovery of GSK-3β inhibitors.
    Liu X; Yu J; Luo Y; Dong H
    Chem Biol Drug Des; 2023 Feb; 101(2):326-339. PubMed ID: 35762873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3beta in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells.
    Cho J; Rameshwar P; Sadoshima J
    J Biol Chem; 2009 Dec; 284(52):36647-36658. PubMed ID: 19858210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α.
    Lo Monte F; Kramer T; Gu J; Anumala UR; Marinelli L; La Pietra V; Novellino E; Franco B; Demedts D; Van Leuven F; Fuertes A; Dominguez JM; Plotkin B; Eldar-Finkelman H; Schmidt B
    J Med Chem; 2012 May; 55(9):4407-24. PubMed ID: 22533818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel interaction between Glycogen Synthase Kinase-3α (GSK-3α) and the scaffold protein Receptor for Activated C-Kinase 1 (RACK1) regulates the circadian clock.
    Zeidner LC; Buescher JL; Phiel CJ
    Int J Biochem Mol Biol; 2011; 2(4):318-27. PubMed ID: 22187666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.
    Abdo Moustafa E; Abdelrasheed Allam H; Fouad MA; El Kerdawy AM; Nasser Eid El-Sayed N; Wagner C; Abdel-Aziz HA; Abdel Fattah Ezzat M
    Bioorg Chem; 2024 May; 146():107324. PubMed ID: 38569322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Bio-evaluation and Molecular Dynamics Simulation of Novel GSK-3β Inhibitors.
    Lyu W; Li Q; Li Q; Chen Y; Wang Y; Tang T; Feng F; Chi H; Li Y; Liu W; Sun H
    Mol Inform; 2021 Dec; 40(12):e2060031. PubMed ID: 34323388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
    Darrington RS; Campa VM; Walker MM; Bengoa-Vergniory N; Gorrono-Etxebarria I; Uysal-Onganer P; Kawano Y; Waxman J; Kypta RM
    Int J Cancer; 2012 Sep; 131(6):E872-83. PubMed ID: 22539113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation and energetic analyses of novel GSK-3β inhibitors.
    Zhang D; Liu L; Pang L; Jin Q; Ke K; Hu M; Yang J; Ma W; Xie H; Chen X
    J Cell Biochem; 2018 Apr; 119(4):3510-3518. PubMed ID: 29144001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid Leukemia.
    Neumann T; Benajiba L; Göring S; Stegmaier K; Schmidt B
    J Med Chem; 2015 Nov; 58(22):8907-19. PubMed ID: 26496242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of 5-(Heteroarylmethylene)hydantoins as Glycogen Synthase Kinase-3β Inhibitors.
    Schneider NO; Gilreath K; Burkett DJ; St Maurice M; Donaldson WA
    Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.